Basel, North West Switzerland
Location: Basel
Discipline: Medicine/Pharmacology
Medicine Apr 16
Roche to present new data at AAN highlighting extensive research for OCREVUS and expanding neuroscience pipeline.
Medicine Apr 6

Roche completes acquisition of Flatiron Health. Roche today announced that it has completed the acquisition of Flatiron Health, a privately held healthcare technology and services company headquartered in New York City, US.

Medicine Mar 20

Phase III IMpower131 study showed Roche's TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death in the initial treatment of people with a type of advanced squamous lung cancer.

Medicine Feb 8

Roche purchases shares in tender offer for Ignyta, Inc. Roche and Ignyta, Inc.

Medicine Mar 28

Roche announces Japanese court ruled in favour of Chugai in Hemlibra patent litigation.

Medicine Feb 27

European Commission approves Roche's Hemlibra for people with haemophilia A with inhibitors.

Medicine Jan 10

Roche commences tender offer for all shares of Ignyta, Inc. for US$ 27.00 per share in cash Roche today announced that it has commenced a cash tender offer for all of the outstanding shares of common stock of Ignyta, Inc.

website preview


Medicine and Life Sciences